J
José Luis Sánchez-Quesada
Researcher at Hospital de Sant Pau
Publications - 137
Citations - 3675
José Luis Sánchez-Quesada is an academic researcher from Hospital de Sant Pau. The author has contributed to research in topics: Lipoprotein & Apolipoprotein B. The author has an hindex of 34, co-authored 122 publications receiving 3294 citations. Previous affiliations of José Luis Sánchez-Quesada include Autonomous University of Barcelona & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke
Núria Puig,Pol Camps-Renom,Mercedes Camacho,A. Aguilera-Simón,Francesc Jiménez-Altayó,Alejandro Fernández-León,Rebeca Marín,Joan Martí-Fàbregas,José Luis Sánchez-Quesada,Elena Jiménez-Xarrié,Sonia Benitez +10 more
TL;DR: In this paper , the authors identify plasma inflammatory biomarkers associated with plaque inflammation according to 18F-FDG uptake and predict stroke recurrence in patients with atherothrombotic stroke.
Journal ArticleDOI
Caracterización de la subfracción electronegativa de la LDL en individuos con hipercolesterolemia familiar
TL;DR: In this article, a caracterización fisico-quimica and biologic of LDL(−) aislada of pacientes with hipercolesterolemia familiar was presented.
Journal ArticleDOI
Presence of Ceramidase Activity in Electronegative LDL
Núria Puig,José Antonio Marín Rives,Montserrat Estruch,A. Aguilera-Simón,Noemi Rotllan,Mercedes Camacho,Nuria Colomé,Francesc Canals,José Luis Sánchez-Quesada,Sonia Benitez +9 more
TL;DR: In this paper , the putative presence of ceramidase (CDase) activity was analyzed to explain the increased sphingosine content in LDL(−), which typically derives from Cer degradation.
Book ChapterDOI
Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo.
Andrea Rivas-Urbina,Noemi Rotllan,David Santos,Josep Julve,José Luis Sánchez-Quesada,Joan Carles Escolà-Gil +5 more
TL;DR: The general principles and techniques described herein can be applied to evaluate the effect of different experimental pathophysiological conditions or the efficacy of different therapeutic strategies on the modulation of in vivo cholesterol efflux to plasma acceptors and the rate of reverse transport of unesterified cholesterol from macrophages to feces in mice.
Journal ArticleDOI
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke
Eduardo Garcia,Pol Camps-Renom,Núria Puig,Alejandro Fernández-León,A. Aguilera-Simón,Aleyda Benitez-Amaro,Arnau Besora Solé,David Vilades,José Luis Sánchez-Quesada,Joan Martí-Fàbregas,Elena Jiménez-Xarrié,Sonia Benitez,Vicenta Llorente-Cortés +12 more
TL;DR: In this paper , the authors evaluated the performance of soluble low-density lipoprotein receptor-related protein 1 (sLRP1) as an indicator of carotid plaque inflammation.